Literature DB >> 25125326

Probing the size limit for nanomedicine penetration into Burkholderia multivorans and Pseudomonas aeruginosa biofilms.

Katrien Forier1, Anne-Sophie Messiaen2, Koen Raemdonck3, Hans Nelis2, Stefaan De Smedt3, Jo Demeester3, Tom Coenye2, Kevin Braeckmans4.   

Abstract

Encapsulation of antibiotics into nanoparticles is a potential strategy to eradicate biofilms. To allow further optimization of nanomedicines for biofilm eradication, the influence of the nanoparticle size on the penetration into dense biofilm clusters needs to be investigated. In the present study, the penetration of nanoparticles with diameters ranging from 40 to 550 nm into two biofilms, Burkholderia multivorans LMG 18825 and Pseudomonas aeruginosa LMG 27622, was evaluated using confocal microscopy. Through image analysis, the percentage of particles able to penetrate into dense biofilm clusters was calculated. The size cut off for optimal penetration into biofilm clusters was located around 100-130 nm for both biofilms. The mesh size of the biofilm matrix and the size of the channels in between the bacteria of the clusters are two factors which likely play a role in the exclusion of the larger particles. For B. multivorans, a sharp drop in the penetration into the clusters is seen for particles larger than 130 nm while for P. aeruginosa, a more gradual decrease in penetration could be observed. The overall penetration of the nanoparticles was slightly lower for P. aeruginosa than for B. multivorans. Based on these results, it could be concluded that nanocarriers of about 100 nm and smaller are good candidates to improve the treatment of chronic pulmonary biofilms in CF patients. Furthermore, the confocal microscopy method demonstrated here is a useful tool to assess the penetration of nanomedicines in biofilm clusters. Such information is important to optimize nanomedicine formulations for the treatment of biofilm infections.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Burkholderia cepacia complex; Confocal microscopy; Cystic fibrosis; Liposome; Nanomedicine; Pseudomonas aeruginosa

Mesh:

Substances:

Year:  2014        PMID: 25125326     DOI: 10.1016/j.jconrel.2014.07.061

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  20 in total

1.  Role of Viscoelasticity in Bacterial Killing by Antimicrobials in Differently Grown Pseudomonas aeruginosa Biofilms.

Authors:  René T Rozenbaum; Henny C van der Mei; Willem Woudstra; Ed D de Jong; Henk J Busscher; Prashant K Sharma
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

2.  Enzyme-encapsulating polymeric nanoparticles: A potential adjunctive therapy in Pseudomonas aeruginosa biofilm-associated infection treatment.

Authors:  Chendong Han; James Goodwine; Nicholas Romero; Kyle S Steck; Karin Sauer; Amber Doiron
Journal:  Colloids Surf B Biointerfaces       Date:  2019-09-20       Impact factor: 5.268

3.  Inhibition of Staphylococcus aureus and Pseudomonas aeruginosa biofilms by quatsomes in low concentrations.

Authors:  Dong Dong; Nicky Thomas; Mahnaz Ramezanpour; Alkis J Psaltis; Shuman Huang; Yulin Zhao; Benjamin Thierry; Peter-John Wormald; Clive A Prestidge; Sarah Vreugde
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-05

Review 4.  The Mucus Barrier to Inhaled Gene Therapy.

Authors:  Gregg A Duncan; James Jung; Justin Hanes; Jung Soo Suk
Journal:  Mol Ther       Date:  2016-09-20       Impact factor: 11.454

5.  Interplay between host-microbe and microbe-microbe interactions in cystic fibrosis.

Authors:  Catherine R Armbruster; Tom Coenye; Lhousseine Touqui; Jennifer M Bomberger
Journal:  J Cyst Fibros       Date:  2019-11-02       Impact factor: 5.482

6.  Short Palate, Lung, and Nasal Epithelial Clone 1 Has Antimicrobial and Antibiofilm Activities against the Burkholderia cepacia Complex.

Authors:  Saira Ahmad; Jean Tyrrell; William G Walton; Ashutosh Tripathy; Matthew R Redinbo; Robert Tarran
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

Review 7.  Lipid-based nanosystems for targeting bone implant-associated infections: current approaches and future endeavors.

Authors:  Magda Ferreira; Sandra Aguiar; Ana Bettencourt; Maria Manuela Gaspar
Journal:  Drug Deliv Transl Res       Date:  2021-02       Impact factor: 4.617

8.  Concanavalin A-targeted mesoporous silica nanoparticles for infection treatment.

Authors:  Marina Martínez-Carmona; Isabel Izquierdo-Barba; Montserrat Colilla; María Vallet-Regí
Journal:  Acta Biomater       Date:  2019-07-03       Impact factor: 8.947

Review 9.  Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections.

Authors:  Jessa Marie V Makabenta; Ahmed Nabawy; Cheng-Hsuan Li; Suzannah Schmidt-Malan; Robin Patel; Vincent M Rotello
Journal:  Nat Rev Microbiol       Date:  2020-08-19       Impact factor: 60.633

Review 10.  Therapy of infected wounds: overcoming clinical challenges by advanced drug delivery systems.

Authors:  Pia Kaiser; Jana Wächter; Maike Windbergs
Journal:  Drug Deliv Transl Res       Date:  2021-02-20       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.